Lenox Wealth Management, Inc. - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 136 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.11 and the average weighting 0.8%.

Quarter-by-quarter ownership
Lenox Wealth Management, Inc. ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$8,000
-20.0%
1,0350.0%0.00%0.0%
Q4 2017$10,000
-16.7%
1,0350.0%0.00%
-25.0%
Q3 2017$12,000
-29.4%
1,0350.0%0.00%
-42.9%
Q2 2017$17,000
+13.3%
1,0350.0%0.01%
-36.4%
Q1 2017$15,000
+7.1%
1,0350.0%0.01%0.0%
Q4 2016$14,000
-26.3%
1,0350.0%0.01%
-26.7%
Q3 2016$19,000
+26.7%
1,0350.0%0.02%
+36.4%
Q2 2016$15,000
+25.0%
1,0350.0%0.01%
+37.5%
Q1 2016$12,000
-14.3%
1,0350.0%0.01%
-27.3%
Q4 2015$14,0001,0350.01%
Other shareholders
LEXICON PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Ulys, L.L.C. 4,321,214$62,009,000100.00%
Artal Group S.A. 57,517,977$825,383,00017.04%
NEA Management Company, LLC 2,382,286$34,186,0001.77%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 35,714$512,0001.49%
BRIDGER MANAGEMENT, LLC 1,029,926$14,779,0000.95%
FALCON POINT CAPITAL, LLC 287,809$4,130,0000.71%
HANCOCK WHITNEY CORP 664,025$9,529,0000.40%
KINGDON CAPITAL MANAGEMENT, L.L.C. 494,380$7,094,0000.39%
ELLINGTON MANAGEMENT GROUP LLC 11,700$168,0000.23%
Convergence Investment Partners, LLC 114,157$1,638,0000.22%
View complete list of LEXICON PHARMACEUTICALS INC shareholders